Impact of a diet and activity health promotion intervention on regional patterns of DNA methylation.
DNA methylation
Diet
Lifestyle
Physical activity
Randomized trial
Journal
Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977
Informations de publication
Date de publication:
11 09 2019
11 09 2019
Historique:
received:
29
04
2019
accepted:
15
07
2019
entrez:
12
9
2019
pubmed:
12
9
2019
medline:
17
6
2020
Statut:
epublish
Résumé
Studies demonstrate the impact of diet and physical activity on epigenetic biomarkers, specifically DNA methylation. However, no intervention studies have examined the combined impact of dietary and activity changes on the blood epigenome. The objective of this study was to examine the impact of the Make Better Choices 2 (MBC2) healthy diet and activity intervention on patterns of epigenome-wide DNA methylation. The MBC2 study was a 9-month randomized controlled trial among adults aged 18-65 with non-optimal levels of health behaviors. The study compared three 12-week interventions to (1) simultaneously increase exercise and fruit/vegetable intake, while decreasing sedentary leisure screen time; (2) sequentially increase fruit/vegetable intake and decrease leisure screen time first, then increase exercise; (3) increase sleep and decrease stress (control). We collected blood samples at baseline, 3 and 9 months, and measured DNA methylation using the Illumina EPIC (850 k) BeadChip. We examined region-based differential methylation patterns using linear regression models with the false discovery rate of 0.05. We also conducted pathway analysis using gene ontology (GO), KEGG, and IPA canonical pathway databases. We found no differences between the MBC2 population (n = 340) and the subsample with DNA methylation measured (n = 68) on baseline characteristics or the impact of the intervention on behavior change. We identified no differentially methylated regions at baseline between the control versus intervention groups. At 3 versus 9 months, we identified 154 and 298 differentially methylated regions, respectively, between controls compared to pooled samples from sequential and simultaneous groups. In the GO database, we identified two gene ontology terms related to hemophilic cell adhesion and cell-cell adhesion. In IPA analysis, we found pathways related to carcinogenesis including PI3K/AKT, Wnt/β-catenin, sonic hedgehog, and p53 signaling. We observed an overlap between 3 and 9 months, including the GDP-L-fucose biosynthesis I, methylmalonyl metabolism, and estrogen-mediated cell cycle regulation pathways. The results demonstrate that the MBC2 diet and physical activity intervention impacts patterns of DNA methylation in gene regions related to cell cycle regulation and carcinogenesis. Future studies will examine DNA methylation as a biomarker to identify populations that may particularly benefit from incorporating health behavior change into plans for precision prevention.
Sections du résumé
BACKGROUND
Studies demonstrate the impact of diet and physical activity on epigenetic biomarkers, specifically DNA methylation. However, no intervention studies have examined the combined impact of dietary and activity changes on the blood epigenome. The objective of this study was to examine the impact of the Make Better Choices 2 (MBC2) healthy diet and activity intervention on patterns of epigenome-wide DNA methylation. The MBC2 study was a 9-month randomized controlled trial among adults aged 18-65 with non-optimal levels of health behaviors. The study compared three 12-week interventions to (1) simultaneously increase exercise and fruit/vegetable intake, while decreasing sedentary leisure screen time; (2) sequentially increase fruit/vegetable intake and decrease leisure screen time first, then increase exercise; (3) increase sleep and decrease stress (control). We collected blood samples at baseline, 3 and 9 months, and measured DNA methylation using the Illumina EPIC (850 k) BeadChip. We examined region-based differential methylation patterns using linear regression models with the false discovery rate of 0.05. We also conducted pathway analysis using gene ontology (GO), KEGG, and IPA canonical pathway databases.
RESULTS
We found no differences between the MBC2 population (n = 340) and the subsample with DNA methylation measured (n = 68) on baseline characteristics or the impact of the intervention on behavior change. We identified no differentially methylated regions at baseline between the control versus intervention groups. At 3 versus 9 months, we identified 154 and 298 differentially methylated regions, respectively, between controls compared to pooled samples from sequential and simultaneous groups. In the GO database, we identified two gene ontology terms related to hemophilic cell adhesion and cell-cell adhesion. In IPA analysis, we found pathways related to carcinogenesis including PI3K/AKT, Wnt/β-catenin, sonic hedgehog, and p53 signaling. We observed an overlap between 3 and 9 months, including the GDP-L-fucose biosynthesis I, methylmalonyl metabolism, and estrogen-mediated cell cycle regulation pathways.
CONCLUSIONS
The results demonstrate that the MBC2 diet and physical activity intervention impacts patterns of DNA methylation in gene regions related to cell cycle regulation and carcinogenesis. Future studies will examine DNA methylation as a biomarker to identify populations that may particularly benefit from incorporating health behavior change into plans for precision prevention.
Identifiants
pubmed: 31506096
doi: 10.1186/s13148-019-0707-0
pii: 10.1186/s13148-019-0707-0
pmc: PMC6737702
doi:
Banques de données
ClinicalTrials.gov
['NCT01249989']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
133Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL075451
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000150
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002389
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014599
Pays : United States
Références
Nutrients. 2015 Jan 30;7(2):922-47
pubmed: 25647662
Int J Cancer. 2007 Feb 1;120(3):656-63
pubmed: 17096326
Sci Rep. 2018 Jan 31;8(1):1968
pubmed: 29386551
Contemp Clin Trials. 2015 Mar;41:85-92
pubmed: 25625810
J Nutr. 2015 Apr;145(4):783-90
pubmed: 25833781
Int J Clin Exp Pathol. 2015 Dec 01;8(12):16073-80
pubmed: 26884884
MMWR Surveill Summ. 2016 Apr 29;65(4):1-142
pubmed: 27124212
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Eur J Cancer. 2013 Jun;49(9):2199-206
pubmed: 23473616
Am J Clin Nutr. 2017 Apr;105(4):991-1000
pubmed: 28275132
Appl Physiol Nutr Metab. 2018 Mar;43(3):233-239
pubmed: 29049890
Drug Discov Today. 2014 Jul;19(7):1015-8
pubmed: 24632002
J Cell Physiol. 2015 Apr;230(4):752-7
pubmed: 25294580
Sci Rep. 2017 Nov 9;7(1):15134
pubmed: 29123172
Cell Tissue Res. 2014 Mar;355(3):647-56
pubmed: 24562377
Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33
pubmed: 27322403
Diabetes. 2012 Dec;61(12):3322-32
pubmed: 23028138
Adv Genet. 2010;71:237-55
pubmed: 20933131
FEBS Lett. 2017 Oct;591(19):2992-3006
pubmed: 28685841
BMC Genomics. 2015 Oct 28;16:873
pubmed: 26510534
Int J Mol Sci. 2017 Mar 02;18(3):
pubmed: 28257124
Epigenetics. 2018;13(6):605-626
pubmed: 29927686
Diabetologia. 2016 Apr;59(4):799-812
pubmed: 26750116
Epigenetics Chromatin. 2015 Jan 27;8:6
pubmed: 25972926
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):210-216
pubmed: 28344356
BMC Genomics. 2017 Jan 5;18(1):29
pubmed: 28056786
Acta Physiol Scand. 2000 Apr;168(4):657-65
pubmed: 10759602
Int J Sports Med. 2010 Sep;31(9):671-5
pubmed: 20200803
Genome Biol. 2014 Feb 20;15(2):R37
pubmed: 24555846
J Med Internet Res. 2018 Jun 19;20(6):e10528
pubmed: 29921561
Mol Med. 2017 Sep;23:188-195
pubmed: 28741645
Forensic Sci Int Genet. 2018 May;34:e15-e17
pubmed: 29472117
Epigenetics. 2011 Mar;6(3):293-9
pubmed: 21178401
J Physiol. 2016 Aug 1;594(15):4267-82
pubmed: 26931178
Eur J Cancer. 2010 Sep;46(14):2593-604
pubmed: 20843488
Epigenomics. 2017 May;9(5):769-787
pubmed: 28517981
Mol Genet Metab. 2017 Dec;122(4):145-152
pubmed: 29033250
PLoS One. 2013 Oct 29;8(10):e78350
pubmed: 24205208
PLoS One. 2014 Apr 21;9(4):e92088
pubmed: 24752326
Oncotarget. 2017 Apr 4;8(14):23237-23245
pubmed: 28423572
Oncol Lett. 2016 May;11(5):3033-3039
pubmed: 27123059
J Appl Physiol (1985). 2017 Apr 1;122(4):752-766
pubmed: 28104750
Sci Rep. 2018 Feb 14;8(1):3016
pubmed: 29445118
J Nutr. 2011 Jun;141(6):1165-71
pubmed: 21525250
J Public Health Policy. 2015 May;36(2):231-43
pubmed: 25611892
Am Soc Clin Oncol Educ Book. 2015;:e66-73
pubmed: 25993238
Front Genet. 2018 Oct 30;9:514
pubmed: 30425730
Nucleic Acids Res. 2013 Apr;41(7):e90
pubmed: 23476028
Genomics. 2011 Oct;98(4):288-95
pubmed: 21839163
PLoS One. 2014 Feb 24;9(2):e89577
pubmed: 24651368
Hum Genet. 2004 Jun;115(1):81-9
pubmed: 15088139
J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S67-9
pubmed: 25291132
Sports Med. 2014 Apr;44(4):429-36
pubmed: 24399634
Exerc Immunol Rev. 2015;21:26-41
pubmed: 25826329
Environ Health Perspect. 2015 Jan;123(1):64-71
pubmed: 25325195
Methods Mol Biol. 2019;1878:173-191
pubmed: 30378076
Cell Metab. 2012 Mar 7;15(3):405-11
pubmed: 22405075
J Dermatol Sci. 2018 Apr;90(1):35-45
pubmed: 29305258
Prev Med. 2012 Mar-Apr;54(3-4):229-33
pubmed: 22313796
Sci Rep. 2019 Mar 12;9(1):4251
pubmed: 30862794
Genes Nutr. 2015 Sep;10(5):480
pubmed: 26183162
Clin Epigenetics. 2017 Apr 21;9:40
pubmed: 28439315
Genomics. 2014 Nov;104(5):352-7
pubmed: 25179374
Genom Data. 2016 May 26;9:22-4
pubmed: 27330998
Bioinformatics. 2017 Feb 15;33(4):558-560
pubmed: 28035024
Mol Med Rep. 2018 Jan;17(1):1699-1709
pubmed: 29138870
JAMA. 2013 Aug 14;310(6):591-608
pubmed: 23842577
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
PLoS Genet. 2013 Jun;9(6):e1003572
pubmed: 23825961
Forensic Sci Int Genet. 2019 Jan;38:1-8
pubmed: 30300865
Epigenetics. 2012 Jun 1;7(6):606-14
pubmed: 22531363
Hypertension. 2014 Apr;63(4):663-4
pubmed: 24396026
Adv Clin Exp Med. 2019 Jun;28(6):711-718
pubmed: 30740945